Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALLY DISINTEGRATINGGeneric

ARIPIPRAZOLE

ARIPIPRAZOLE

Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview ARIPIPRAZOLE is listed in Drugs@FDA under application 078612 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient ARIPIPRAZOLE Form and strength TABLET; ORALLY DISINTEGRATING - 30MG Sponsor BARR LABS INC Submission history Latest submission status date: 2012-11-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARIPIPRAZOLE is listed in Drugs@FDA under application 078612 (ANDA). Marketing status: None (Tentative Approval) Active ingredient ARIPIPRAZOLE Form and strength TABLET; ORALLY DISINTEGRATING - 30MG Sponsor BARR LABS INC Submission history Latest submission status date: 2012-11-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.